A Study on The Knowledge of Tetanus Immunization Among Internees in A Government Medical College of Kolkata
Keywords:
Tetanus, internees, immunization, woundAbstract
The current study was undertaken to assess the knowledge of the internees regarding tetanus immunization in children, pregnant women and adults as per the NIS and the guidelines regarding tetanus immunization in relation to the wound categories depending on the immunisation status of the patients. A pre tested questioner used to access knowledge among 108 internees. 57.4% internees were not aware of the number of doses of tetanus vaccine recommended for children under the age of 16 years and 76.8% internees were not aware of the number of doses of tetanus vaccine recommended for adults over the age of 16 years. More than 90% of the internees considered contaminated wounds, animal bites, burn injuries and wounds greater than 6 hours old to be tetanus prone. 91.7% of internees had considered wounds greater than 6hours old as tetanus prone and 5.6% did not consider this wound to be tetanus prone. On the other hand, 97.2% of internees had considered contaminated wounds and animal bite to be tetanus prone and 2.8% did not consider. While 93.5% of internees considered burn injuries to be prone to the development of tetanus, 6.5% of internees thought otherwise. 13% of the internees did not consider human bite to be tetanus prone. 25% of the internees considered every cut injury to be tetanus prone. Better TT awareness of tetanus prophylaxis recommendations is necessary and tetanus prophylaxis recommendations may be more effective if they are better adhered to at the ED and the other departments that are involved in providing tetanus prophylaxis to their patients.
References
1 Savage EJ, Nash S, McGuiness A, Crowcroft NS. Audit of tetanus prevention knowledge and practices in accident emergency departments in England. Emerg Med J 2007;417-421
2 Borrow R, Balmer P, Roper HM. Tetanus Update. The immunological basis for immunisation series Module 3: Tetanus update 2006.WHO; 2006.
3 WHO. Maternal and Neonatal Tetanus Elimination by 2005.WHO 2000 (Available at www.who.int/vaccines_documents last accessed on 1.10.2011)
4 Park K. Park’s Textbook of Preventive & Social Medicine 20th Edition Banarsidas Bhanot Publishers 2009:272
5 Peeters RF, Alisjahbana, Meheus AZ. Preventing neonatal tetanus: traditional birth atetanus toxoidendants or immunization. Downloaded from www.heapol.oxfordjournals.org on January 17, 2011
6 Neonatal Tetanus Elimination. Pan American Health Organization 2005. Available at htetanus toxoidp://www.paho.org/english/ad/fch/im/FieldGui de_NNT.pdf last accessed on 1.10.2011)
7 Abrutyn E. Principles of Harrison’s Internal Medicine 17th Editiion Mcgraw hill Medical 2008:898-900
8 Srivastava P, Brown K, Chen J, Kretsinger K, Roper MH. Trends in tetanus epidemiology in the United States, 1972--2001. 39th National Immunization Conference, Washington, DC,2005; March: 21--24
9 Kishore J. National Health Programmes of India 9th Edition Century Publications 2011:158
10 Talan DA, Abrahamian FM, Moran GJ, Mower WR, Alagappan K, Tiffany BR, Pollack CV, Steele MT, Dunbar LM, Bajani MD, Weyant RS, Ostroff SM. Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Annals of Emergency Medicine 2004: 43(3):305-14
11 Ahmed SI, Baig L, Thaves IH, Siddiqui MI, Jafery SI, Javed A. Knowledge atetanus toxoiditude and practices of general practitioners in Karachi District Central about tetanus immunization in adults. J Pak Med assoc 2001;367-369
12 Dabas P, Agarwal CM, Kumar R, Taneja DK, Ingle GK, Saha R. Knowledge of general public and health professionals about tetanus immunization. Indian J Paediatr 2005;1035-1038
13 Ministry of Health & Family Welfare, Government of India. Review of Universal Immunisation Program in India 2004. New Delhi, 2005.
14 Abramson JH, Abramson ZH. Survey Methods in Community Medicine 5th edition Churchill Livingstone 1999:102
15 Blencowe H, Lawn J, Vandelear J, Roper M, cousens S. tetanus toxoid immunisation to reduce mortality from neonatal tetanus International Journal of Epidemiology. 2010:102-109
16 Kishore J. National Health Programmes of India 9th Edition. Century Publications 2011:158
17 Monitoring immunization services using the lot Quality technique. Department of Vaccines and Biologicals. WHO
18 Govt. of India (2006). Health information of India 2005, Ministry of Health & Family Welfare, New Delhi.
19 Ryder RW et al. Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. The Journal of Pediatrics 1993; 122:697–702.
20 Moss WJ et al. Immunization of children at risk of infection with human immunodeficiency virus. Bulletin, Geneva, World Health Organization 2003;81:6170
21 Borkowsky W et al. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. The Journal of Pediatrics 1992; 120:371–375.
22 Rosenblatt HM et al. Tetanus immunity after diphtheria, tetanus toxoids and acellular pertussis vaccination in children with clinically stable HIV infection. The Journal of Allergy and Clinical Immunology 2005;116:698–703.
23 Melvin AJ, Mohan KM. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics 2003; 111:641–644.
24 Kurtzhals JAL et al.. Immunity against diphtheria and tetanus in human immunodeficiency virus —infected Danish men born 1950–1959. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 1992; 100:803–808.
25 Kroon FP et al. Immunoglobulin (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid. Clinical and Diagnostic Laboratory Immunology, 1999; 6:352–355.
26 Dieye TN et al. Immunologic and virologic response after tetanus toxoid booster among HIV-1 and HIV-2-infected Senegalese individuals.Vaccine 2002;20:905–913
27 Bonetti TCS et al. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1 infected women. Vaccine 2004; 22:3707–3712.
28 Immunisation Practice advisory Commitetanus toxoidee (CIP), CDC Atlanta. Diptheria, tetanus and pertusis: Recommendations and other preventive measures. MMWR 1991;1-28
29 Eilbert WP. Dog,Cat and human bites: Providing safe and cost effective Treatment in the ED. Emergency Medicine Practice 2003;5(8)
30 Downloaded from info@bpl.co.uk. Last accessed on 1/10/2011.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
